Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | WKT909C62B |
InChI Key | QGZYDVAGYRLSKP-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C24H27N5O3 |
Molecular Weight | 433.51 |
AlogP | 4.13 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 11.0 |
Polar Surface Area | 107.45 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 32.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class I
|
- | 38-190 | - | - | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIa
|
- | 1400-1400 | - | - | - | |
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | 3-27 | - | - | - | |
Unclassified protein
|
- | 37-51 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Klatskin Tumor | 1 | D018285 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1316214-52-4 |
ChEBI | 95073 |
ChEMBL | CHEMBL2364628 |
DrugBank | DB12376 |
EPA CompTox | DTXSID40157148 |
FDA SRS | WKT909C62B |
Guide to Pharmacology | 7010 |
PDB | AH4 |
PubChem | 53340666 |
SureChEMBL | SCHEMBL574580 |
ZINC | ZINC000089630354 |